Relationship between IL-6 and COVID-19: To be considered during treatment
| dc.contributor.author | Vatansever H.S. | |
| dc.contributor.author | Becer E. | |
| dc.date.accessioned | 2025-04-10T11:06:11Z | |
| dc.date.available | 2025-04-10T11:06:11Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | The detection and control of pro-inflammatory response is crucial in the early stages of viral infection. Coronavirus disease 2019 (COVID-19) is an emerging viral disease of global concern and optimal treatment has yet to be determined. Unknown response of treatment of COVID-19 is important during patient monitoring. IL-6 is one of the key cytokines after activated macrophages. Therefore, control of systemic IL-6 levels in SARS-CoV-2 infected patients may be a parameter for COVID-19 disease. This review is focused on the induction of IL-6 after viral infections as a target molecule for monitoring cellular response. © 2021 Future Medicine Ltd. | |
| dc.identifier.DOI-ID | 10.2217/fvl-2020-0168 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14701/46552 | |
| dc.publisher | Future Medicine Ltd. | |
| dc.title | Relationship between IL-6 and COVID-19: To be considered during treatment | |
| dc.type | Review |